Genética y epigenética de los SMD: del biomarcador a la terapia - page 54

54
MOLECULAR CYTOGENETICS GROUP - CNIO
Sandra Rodriguez
University of Navarra
Department of Genetics
MºJose Calasanz
Foundation for Applied Medical
Research Division of Cancer and
Area of Cell Therapy and
Hematology Service
,
Xabi Aguirre
Felipe Prósper,
Hospital de la Fe (Valencia)
José Cervera
Miguel Angel Sanz
Fundación José Carreras (Barcelona)
Francesc Solé
1...,44,45,46,47,48,49,50,51,52,53 55,56,57,58,59,60,61,62,63,64,...69
Powered by FlippingBook